| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $88.5M | — | +44.6% |
| SG&A Expense | $23.8M | — | +25.1% |
| Operating Income | -$112.3M | — | -54.4% |
| Pre-tax Income | -$104.9M | — | -62.3% |
| Income Tax | -$2.6M | — | -702.1% |
| Net Income | -$102.3M | — | -57.3% |
| EPS (Basic) | -$1.17 | — | -41.0% |
| EPS (Diluted) | -$1.17 | — | -41.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $545.9M | +174.1% | +367.9% |
| Short-term Investments | $548.9M | +56.9% | +26.8% |
| Current Assets | $1.11B | +97.4% | +95.7% |
| Total Assets | $1.39B | +119.0% | +86.6% |
| Current Liabilities | $39.8M | -4.7% | +24.3% |
| Total Liabilities | $49.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$88.9M | — | -44.2% |
| Capital Expenditures | $133K | — | +209.3% |
| Investing Cash Flow | -$407.3M | — | -1280.2% |
| Financing Cash Flow | $843.0M | — | — |
| Free Cash Flow | -$89.0M | — | -44.3% |
| +24.6% |
| Stockholders' Equity | $1.34B | +130.0% | +90.0% |